Loading...
8 Russia Diabetes Care Drugs Reports
Country Covered: Russia
Study Period: 2019 - 2030
Major Players: Novo Nordisk, Sanofi, AstraZeneca, Boehringer Ingelheim, Eli Lilly and Company
Country Covered: Russia
Study Period: 2019 - 2030
Major Players: AstraZeneca, Eli Lilly and Company, Boehringer Ingelheim, Novo Nordisk, Sanofi
Country Covered: Russia
Study Period: 2019 - 2030
Major Players: Novo Nordisk, Sanofi, Eli Lilly and Company, AstraZeneca, Biocon
Country Covered: Russia
Study Period: 2019 - 2030
Major Players: Sanofi, Eli Lilly and Company, AstraZeneca, Astellas Pharma, Janssen
Country Covered: Russia
Study Period: 2019 - 2030
Major Players: Eli Lilly and Company, AstraZeneca, Novo Nordisk, Sanofi, Boehringer Ingelheim
Country Covered: Russia
Study Period: 2019 - 2030
Major Players: Teva Pharmaceutical Industries, Bristol-Myers Squibb, AstraZeneca, Sanofi, Merck
Country Covered: Russia
Study Period: 2019 - 2030
Major Players: Boehringer Ingelheim, Sanofi, Merck, Eli Lilly and Company, Novo Nordisk
Country Covered: Russia
Study Period: 2019 - 2030
Major Players: Eli Lilly and Company, Astellas Pharma, Sanofi, Janssen, AstraZeneca
